Softgel CDMO · Poland · Global Brand Programmes

Softgel Capsule Contract Manufacturing

Custom softgel development and contract manufacturing for dietary supplement brands: formulation, technology-transfer assessment, scale-up and packaging. Olympia Biosciences™ is a Poland-based European CDMO serving international projects, with each production route scoped to the formula, volume and named launch markets.

AR-GE Durum Tespit Sürecini Başlatın DATA ROOM / LEGAL HUB →

PIS-registered establishment

Gdynia, Polonya

PIS-registered production establishment in Gdynia, Poland (ul. Polska 20).

2009'DAN BERİ

Diyet takviyesi kalite kaydı

17 years of manufacturing food supplements, FSMP and related services without a single quality complaint.

AMACA UYGUN

Analitik kanıt

Ürün kanıt planı gerektirdiğinde, uzmanlaşmış yöntemler kalifiye bağımsız laboratuvarlar tarafından gerçekleştirilir.

ISO/IEC 27001

Bilgi güvenliği

Müşteri Fikri Mülkiyeti ve gizli belgeler, sertifikalı bilgi güvenliği çerçevesi kapsamında korunmaktadır.

Your Manufacturing Brief

What to Send Your Softgel Manufacturer

Whether you are developing a new supplement or moving an established product, these inputs help the team assess fit and define the next paid scope. Share a non-confidential summary first; confidential formula and process documents follow the agreed NDA process.

Formula or development brief: ingredient forms, active dose per capsule, intended fill mass and shell requirements.
Commercial scope: first-order capsule quantity, annual forecast, pack count and target launch date.
Named launch countries, target population, packaging and required shelf life; global distribution needs a market-by-market scope.
For technology transfer: available specifications, Master Batch Record, analytical methods, stability data and current packaging.

Kanıt Protokolü

Hacimden Önce Tekrarlanabilirlik.

We are responsible for formulation, raw-material sourcing, testing and release of every batch; IOC sp. z o.o. is the PIS-registered manufacturer.

Proses Kontrolü

Ürüne özel kritik süreç parametreleri

Analitik Serbest Bırakma

Ürünle uyumlu kanıt planı

Süreklilik

Scale-up planning against product requirements

Yönetişim

ISO/IEC 27001 bilgi güvenliği çerçevesi

New Development or Existing Formula

Choose the Right Starting Point

New custom softgel: scope formulation questions, target dose, fill and shell compatibility through Paid Discovery before separately commissioned physical validation.
Existing softgel: assess the transfer dossier, source specifications and process evidence to identify gaps before agreeing pilot or commercial manufacturing work.
Sahipliği ve sürekliliği desteklemek üzere tasarlanmış sözleşmeli projeye özel çıktılar; mevcut Olympia platformları ayrı olarak yönetilmeye devam eder.

Paid Discovery scope, deliverables and exclusions →Production formats and MOQ reference →

Uygulama Basamakları

From Softgel Formulation to Commercial Production

Brief and scope

Review the formula or concept, production volumes, markets and available evidence. Agree the appropriate development or transfer scope.

Formulation and evidence plan

Define fill–shell compatibility questions, specifications and required evidence. Paid Discovery is intellectual work; samples and laboratory work are separate.

Validation and scale-up

Commission agreed physical work, external tests or pilot runs under separate paid work orders. Use the results to decide whether to proceed or redesign.

Manufacturing and release

Commercial production follows an accepted quotation, agreed order quantity, quality requirements and payment terms. Batch testing, release and packaging follow the contracted scope.

Softgel Manufacturing · Technical Due Diligence

Evaluate Your Softgel Formula, Shell and Packaging Together

For oil-based supplements, emulsions or semi-solid fills, the purchasing question is not just whether a capsule can be filled. The development brief must connect active dose, raw-material mass, shell compatibility, processing, stability and the final pack. Active dose and total fill mass are different specification inputs.

Yumuşak kapsül kararları, ürünün teknik ve kalite gereklilikleri doğrultusunda değerlendirilir; hiçbir taşıyıcı format veya süreç klinik, stabilite veya ticari bir sonucu garanti etmez.

YUMUŞAK KAPSÜL ÜRETİMİ NEDİR

Yumuşak kapsül üretimi nedir?

Yumuşak kapsül üretimi, uyumlu bir sıvı veya yarı katı dolgu maddesinin etrafında sızdırmaz bir kapsül geliştirir ve üretir. Yumuşak kapsülün doğru format olup olmadığı; dolgu kimyasına, doza, etken madde stabilitesine, kabuk uyumluluğuna, hedeflenen pazara, ambalaj gereksinimlerine ve ticari üretim kısıtlamalarına bağlıdır. Uygunluk, kategori adından hareketle varsayılmamalı, spesifik ürün için değerlendirilmelidir.

Softgel manufacturing requirements: inputs, technical review and decision gates
REQUIREMENT	YOUR INPUT	TECHNICAL REVIEW	DECISION BEFORE PRODUCTION
Fill formulation	Ingredient forms, active dose, carrier oil or semi-solid system and intended fill mass.	Solubility or suspension behaviour, viscosity, oxidation risk and fill–shell compatibility.	Define development questions before committing to a capsule specification.
Shell and capsule format	Gelatin or non-animal preference, capsule size, shape, colour and dietary restrictions.	Polymer suitability, sealing, drying and disintegration requirements for the actual fill.	Confirm the shell route by technical review, not by a generic vegan or gelatin label.
Testing and stability	Product specification, available methods, existing results and target shelf life.	Identity, potency, relevant contaminants, capsule integrity and a product-specific stability protocol.	Agree the evidence plan and separately scoped testing before making shelf-life claims.
Packaging	Bottle or blister brief, capsules per pack, distribution conditions and launch markets.	Moisture, oxygen and light protection requirements alongside capsule compatibility.	Select a packaging specification for evaluation with the finished product.
Scale-up and technology transfer	Batch records, process parameters, historical yields and forecast demand.	Documentation gaps, pilot requirements, sourcing dependencies and production economics.	Scope transfer and industrialisation before accepting a commercial production quotation.

SCROLL HORIZONTALLY TO REVIEW MANUFACTURING REQUIREMENTS

Final Kapısı

Ar-Ge Durum Tespiti Sürecini Başlatın.

Planning a new softgel supplement or a manufacturing transfer? Send a non-confidential brief with target dose, order quantity, packaging, launch countries and timing. The team will assess fit and define the appropriate paid scope before production is quoted.

AR-GE Durum Tespit Sürecini Başlatın Ölçeklendirme Mimarisi Denetimi

Evidence-led format selection | PIS-registered production establishment in Gdynia, Poland (ul. Polska 20) | qualified analytical evidence

Softgel Contract Manufacturing: Buyer Questions

Bir softgelin teknik olarak uygun olup olmadığını ne belirler?

Karar; sıvı veya yarı katı dolgu maddesine, kabuk polimerine, sızdırmazlığa, varsa enterik kaplamaya, ambalajlamaya, hedef rafa ömrüne, doza ve hedeflenen pazara bağlıdır. Bir kategori adı veya ilk fiyat teklifi uyumluluğu garanti edemez.

What is the minimum order quantity for softgel contract manufacturing?

Use the Production Formats & MOQ Reference as the starting point. The accepted order quantity must be confirmed for the formulation, shell, batch configuration and packaging. Specify both capsule count and finished-pack count in your enquiry; they are not interchangeable.

Bir softgel fizibilite incelemesi neleri kapsar?

Ürün özetini tanımlar, kritik uyumluluk ve stabilite sorularını belirler, hangi kanıtların gerekli olduğunu saptar ve formülasyon ile ölçeklendirme kapsamı belirlenmeden önce softgelin uygun rota olup olmadığını kayda geçirir.

Softgel programları nerede geliştirilmekte ve üretilmektedir?

We are responsible for formulation, raw-material sourcing, testing and release of every batch; IOC sp. z o.o. is the PIS-registered manufacturer.

Can I transfer an existing softgel formula to a new manufacturer?

An existing formula can enter a technology-transfer assessment. Provide specifications, a Master Batch Record, raw-material requirements, analytical methods, available stability results and packaging details under the agreed confidentiality process. Transfer scope, missing evidence and any pilot work must be agreed before production is committed.

Formül ve proses dokümantasyonunun mülkiyeti kime aittir?

Sözleşmeli projelere özel çıktıların mülkiyeti ve taşınabilirliği sözleşmede belirtilir. Olympia’nın halihazırda var olan platformları, yeniden kullanılabilir yöntemleri ve üçüncü taraf unsurları ayrı olarak yönetilmeye devam eder.

What determines the cost of custom softgel capsule manufacturing?

Key inputs are ingredient forms and quantities, fill mass, shell system, order volume, testing, packaging and target-market requirements. Development, physical validation, external testing and production are separately scoped. A production price requires current costing and an accepted quotation; a development fee is not a per-capsule production price.

Can I request gelatin or vegetarian softgel capsules?

Include your animal-origin exclusions and shell preference in the brief. Suitability must be confirmed against the fill, process and product requirements. A vegetarian or vegan positioning must be supported by the agreed material documentation; it is not established by the capsule name alone.

How long does a softgel development or production-transfer project take?

Timing depends on documentation readiness, formulation work, material availability, validation, testing and packaging. Share your target launch date and existing evidence so the team can identify dependencies. No fixed production lead time or shelf life is promised before technical and commercial scope is agreed.

Softgel Manufacturer Due Diligence

Global CDMO PortfolioEXPLORE ›Production Formats & MOQ ReferenceEXPLORE ›Formulation and Delivery-System TechnologyEXPLORE ›Supplement Manufacturing for Physician-Led BrandsEXPLORE ›Production Scale-Up and Technology TransferEXPLORE ›Formula IP and ConfidentialityEXPLORE ›

Sıkı B2B / Eğitimsel Ar-Ge Yasal Uyarı Metni

Bu sayfada referans verilen farmakokinetik veriler, klinik referanslar ve bilimsel literatür; yalnızca tıp uzmanları, farmakologlar ve marka geliştiricileri için B2B formülasyon, eğitim ve Ar-Ge amaçlı sunulmaktadır. Olympia Biosciences™ yalnızca bir Sözleşmeli Geliştirme ve Üretim Organizasyonu (CDMO) olarak faaliyet göstermekte olup, nihai tüketici ürünleri üretmemekte, pazarlamamakta veya satmamaktadır.

Küresel Mevzuat ve Sağlık Beyanı Bulunmaması. Bu sayfada yer alan hiçbir ifade, (EC) No 1924/2006 sayılı AB Tüzüğü, U.S. Dietary Supplement Health and Education Act (DSHEA) veya diğer küresel mevzuat çerçeveleri kapsamında bir sağlık beyanı, tıbbi beyan veya hastalık riski azaltma beyanı teşkil etmez. Bu beyanlar ve ham veriler; Food and Drug Administration (FDA), European Food Safety Authority (EFSA) veya Therapeutic Goods Administration (TGA) tarafından değerlendirilmemiştir. Bahsi geçen ham aktif farmasötik bileşenler (API'ler) ve formülasyonlar herhangi bir hastalığı teşhis, tedavi, iyileştirme veya önleme amacı taşımamaktadır.

Müşteri Sorumluluğu. The B2B client who commissions a formulation from Olympia Biosciences™ is responsible for market-specific regulatory compliance, health claim authorisation, labelling and marketing of its finished product, as defined by the applicable agreement.